Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Rifaximin MeSH Descriptor Data 2025


MeSH Heading
Rifaximin
Tree Number(s)
D03.633.400.811.850
D04.345.295.750.850
Unique ID
D000078262
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000078262
Scope Note
A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY.
Entry Term(s)
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
L 105
L-105
Redactiv
Xifaxan
Pharm Action
Anti-Bacterial Agents
Gastrointestinal Agents
Registry Numbers
L36O5T016N
0
CAS Type 1 Name
2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
Public MeSH Note
2019; RIFAXIMIN was indexed under RIFAMYCINS 1983-2018
History Note
2019 (1983)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/05/21
Rifaximin Preferred
L 105 Narrower
Redactiv Narrower
Xifaxan Narrower
page delivered in 0.148s